oxid
phospholipid
control
inflamm
endotheli
barrier
panfeng
fu
konstantin
g
birukov
chicago
ill
level
circul
oxid
phospholipid
oxpl
becom
increas
chronic
acut
patholog
condit
hyperlipidemia
atherosclerosi
increas
intimamedia
thick
patient
system
lupu
erythematosu
vascular
balloon
injuri
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
patholog
associ
inflamm
activ
endotheli
cell
depend
biolog
context
specif
group
phospholipid
oxid
product
oxpl
may
exhibit
proinflammatori
antiinflammatori
effect
review
summar
data
show
dual
role
oxpl
modul
chronic
acut
inflamm
well
oxpl
effect
pulmonari
endotheli
permeabl
recent
report
show
protect
effect
oxpl
model
endotoxin
ventilatorinduc
ali
suggest
potenti
use
oxplderiv
cyclopenthenonecontain
compound
barrierprotect
properti
drug
design
compound
may
repres
new
group
therapeut
agent
treatment
lung
syndrom
associ
acut
inflamm
lung
vascular
leak
translat
research
abbrevi
ali
acut
lung
injuri
camp
cyclic
adenosin
monophosph
connect
segment
ec
endotheli
cell
eno
endotheli
nitric
oxid
synthas
extracellular
signal
kinas
earli
growth
respons
fak
focal
adhes
kinas
ga
gammainterferon
activ
sequenc
gpcr
gproteincoupl
receptor
gpi
glycosylphosphatidylinositol
gtp
guanosin
triphosph
heme
intercellular
adhes
kodiapc
acid
ester
lbp
lp
bind
protein
ldl
lowdens
lipoprotein
lname
nnitrolargininemethyl
ester
lp
lipopolysaccharid
monocyt
chemotact
protein
mlc
myosin
light
chain
mlc
myosin
light
chain
mmldl
minim
modifi
ldl
mrna
messeng
rna
nfkb
nuclear
factor
kb
oxldl
oxid
ldl
oxpapc
oxid
oxpl
oxid
phospholipid
paf
platelet
activ
factor
papc
pape
pap
pecpc
peipc
prostaglandin
pgpc
pka
protein
kinas
pkc
protein
kinas
c
phospholipas
povpc
snglycerophosphocholin
ppar
peroxisom
proliferatoractiv
receptor
ro
reactiv
oxygen
speci
sirna
small
interf
rna
srebp
sterol
respons
element
bind
protein
tf
tissu
factor
tlr
tolllik
receptor
tnfa
tumor
necrosi
factora
upr
unfold
protein
respons
vascular
cell
adhes
vegf
vascular
endotheli
growth
factor
vili
ventilatorinduc
lung
injuri
increas
level
oxid
phospholipid
oxpl
result
enhanc
gener
reactiv
oxygen
speci
ro
decreas
antioxid
defens
involv
certain
patholog
condit
lung
inflamm
ventilatorinduc
lung
injuri
vili
atherosclerosi
cell
apoptosi
cell
membran
phospholipid
phospholipid
contain
circul
lipoprotein
major
sourc
oxpl
cell
membran
lowdens
lipoprotein
ldl
enrich
phospholipid
contain
polyunsatur
fatti
acid
highli
prone
oxid
modif
format
oxpl
initi
either
enzym
lipoxygenas
reactiv
oxygen
speci
ro
oxpl
detect
human
atherosclerot
lesion
aorta
cholesterolf
herit
hyperlipidem
rabbit
one
major
phospholipid
present
plasma
membran
minim
modifi
ldl
mmldl
papc
gener
heterogen
group
oxygen
fulllength
product
compound
oxid
truncat
oxid
residu
present
posit
biolog
activ
fragment
oxpl
fatti
acid
residu
oxid
truncat
includ
snglycerophosphocholin
povpc
pgpc
acid
eater
kodiapc
group
oxpl
peipc
pecpc
repres
oxygen
oxpl
gener
addit
oxygen
atom
fatti
acid
residu
chemic
structur
biolog
activ
oxpl
shown
fig
addit
phosphatidylcholin
class
oxpl
contain
differ
polar
head
fatti
acid
pape
pap
may
undergo
oxid
modif
structur
divers
account
remark
varieti
biolog
activ
oxpl
describ
abil
oxpl
induc
monocyt
adhes
express
demonstr
fragment
oxygen
oxpl
biolog
system
howev
fragment
oxygen
oxpl
exert
differ
even
opposit
effect
exampl
phospholipid
exhibit
barrierprotect
properti
pulmonari
endotheli
cell
ec
consist
barrierprotect
effect
phospholipid
activ
rac
small
guanosin
triphosph
gtp
ase
involv
signal
endotheli
cell
cytoskeleton
furthermor
even
molecul
contain
similar
residu
exhibit
differ
activ
povpc
pgpc
contain
ualdehyd
ucarboxyl
group
respect
povpc
increas
monocyt
neutrophil
bind
ec
addit
povpc
strongli
inhibit
lipopolysaccharidemedi
induct
neutrophil
bind
express
eselectin
protein
messeng
rna
mrna
contrast
pgpc
induc
monocyt
neutrophil
bind
well
express
eselectin
vascular
cell
adhes
molecul
sever
line
evid
reveal
receptormedi
receptorindepend
pathway
involv
oxplmedi
cell
activ
howev
broad
spectrum
effect
divers
chemic
structur
reason
postul
oxpl
may
interact
multipl
receptor
avail
data
suggest
sever
differ
famili
receptor
activ
oxpl
gproteincoupl
receptor
gpcr
previous
shown
oxpl
may
act
bind
gpcr
parhami
et
al
demonstr
treatment
aortic
ec
mmldl
result
satur
dosedepend
increas
cyclic
adenosin
monophosph
camp
level
camp
increas
respons
mmldl
treatment
caus
stimul
gs
complex
inhibit
gi
complex
subsequ
studi
reveal
involv
differ
gpcr
oxplmedi
signal
pathway
nonenzymat
deacyl
enzymat
hydrolysi
oxid
fatti
acyl
chain
releas
posit
oxpl
lipoproteinassoci
phospholipas
also
known
plateletactiv
factor
paf
acetylhydrolas
catalyz
convers
oxpl
lysophospholipid
bind
activ
variou
gpcr
exampl
lysophosphatidylcholin
activ
receptor
wherea
lysophosphatid
acid
stimul
receptor
furthermor
oxpl
similar
structur
paf
consid
potenti
paf
receptor
agonist
major
paflik
lipid
oxid
ldl
oxldl
butanoyl
butenoyl
activ
paf
receptor
oxpl
result
express
monocyt
bind
ec
howev
oxpl
effect
reproduc
activ
paf
receptor
wellrecogn
edemagen
agent
paf
mimic
barrierprotect
effect
oxid
oxpapc
well
induct
vascular
endotheli
growth
factor
vegf
oxpapc
suggest
involv
receptor
mechan
rather
paf
receptor
recent
gscoupl
gpcr
prostaglandin
implic
activ
integrin
stimul
monocyt
bind
ec
induc
oxpapc
peipc
butaprost
specif
agonist
mimick
effect
oxpapc
regul
tumor
necrosi
factoralpha
tnfa
monocytederiv
cell
furthermor
antagonist
block
activ
oxpapc
cell
block
respons
peipc
monocyt
cell
peroxisom
proliferatoractiv
receptor
ppar
line
evid
show
ppar
g
nuclear
receptor
protein
play
essenti
role
regul
gene
activ
fragment
alkyl
phospholipid
oxldl
call
hexadecyl
azelaoyl
phosphatidylcholin
addit
pparg
ppara
may
also
activ
oxpl
compon
povpc
pgpc
furthermor
use
transient
transfect
assay
deler
et
al
demonstr
oxldl
ldl
activ
ppara
dose
depend
ec
without
affect
ppara
protein
express
inhibitori
analysi
show
phospholipas
lipoxygenas
cyclooxygenas
requir
activ
scaveng
receptor
transmembran
glycoprotein
express
monocytesmacrophag
platelet
microvascular
endothelium
implic
put
receptor
oxldl
recent
acyl
chain
oxpl
protrud
plasma
membran
defin
key
recognit
site
macrophag
bind
cell
surfac
two
conserv
posit
charg
amino
acid
lysin
posit
critic
oxpl
oxldl
bind
contrast
implic
oxldl
recognit
macrophag
work
walton
et
al
demonstr
induct
oxpapc
independ
mediat
tolllik
receptor
glycosylphosphatidylinositolanchor
protein
nonreceptormedi
effect
oxpl
addit
receptormedi
mechan
effect
oxpl
probabl
mediat
cell
membran
receptor
exampl
sterol
respons
element
bind
protein
srebp
seem
activ
consequ
cholesterol
deplet
oxpapc
ec
nonreceptor
mechan
oxid
esterifi
fatti
acid
phospholipid
convert
seri
highli
electrophil
ketoaldehyd
isom
readi
adduct
protein
direct
chemic
modif
studi
brame
et
al
provid
new
insight
mechan
oxpl
influenc
function
cardiac
k
channel
suggest
gener
cellular
mechan
alter
membran
function
consequ
oxid
stress
induc
oxpl
use
nbiotin
label
oxpapc
gugiu
et
al
demonstr
bind
oxpapc
cytoskeletonassoci
protein
type
ii
revers
palmitoyl
transmembran
protein
regul
tissu
plasminogen
activ
surfac
smooth
muscl
cell
complex
oxplinduc
effect
endotheli
function
illustr
spectrum
cell
respons
oxpl
cytoskelet
remodel
barrier
function
inflamm
procoagul
activ
redox
reaction
sterol
metabol
unfold
protein
respons
upr
angiogenesi
microarray
studi
show
oxpapc
regul
express
gene
human
aortic
ec
part
discuss
mechan
activ
oxpl
summar
effect
oxpl
vascular
barrier
regul
inflammatori
pathway
oxpl
accumul
oxpl
site
chronic
vascular
inflamm
atherosclerot
lesion
role
propag
process
well
recogn
initi
studi
henriksen
et
al
form
basi
hypothesi
oxid
ldl
might
import
step
atherogenesi
process
subsequ
studi
demonstr
role
oxpl
activ
monocyt
extravas
adhes
induct
inflammatori
cytokin
product
increas
thrombogenesi
well
effect
coagul
redox
balanc
extravas
activ
monocyt
characterist
featur
atherosclerosi
accumul
lipid
lesion
area
numer
studi
clearli
demonstr
oxpl
activ
monocyt
bind
vascular
ec
initi
event
trigger
vascular
inflamm
atherosclerosi
plaqu
format
induc
synthesi
monocytespecif
chemoattract
monocyt
chemotact
protein
monocyteec
adhes
protein
connect
segment
fibronectin
endotheli
membran
protein
bind
monocyt
integrin
caus
firm
adhes
monocyt
ec
oxpapc
promot
surfac
deposit
fibronectin
mediat
increas
rra
activ
decreas
hra
activ
model
oxpapc
increas
camp
level
respons
rra
activ
turn
rra
activ
k
result
activ
integrin
apic
surfac
candid
receptor
mediat
pathway
prostaglandin
receptor
belong
gpcr
famili
agonist
increas
activ
beta
integrin
line
evid
suggest
lipoxygenas
pathway
altern
mechan
regul
oxplinduc
monocyt
adhes
treatment
ec
lipoxygenas
inhibitor
cyclooxygenas
decreas
mmldl
povpcinduc
monocyt
bind
ec
furthermor
addit
hydroperoxi
tetraeno
eicosatetraeno
acid
revers
inhibitori
effect
lipoxygenas
inhibitor
monocyt
bind
importantli
mechan
oxplinduc
monocyt
bind
ec
differ
induc
inflammatori
factor
lipopolysaccharid
lp
tnfa
oxpl
upregul
intercellular
adhes
eselectin
express
upregul
pselectin
lead
select
monocyt
neutrophil
adhes
vascular
endothelium
upregul
proinflammatori
cytokin
evid
indic
oxpl
increas
express
sever
chemokin
includ
macrophag
inflammatori
alpha
b
growthrel
protein
describ
well
previou
review
cytokin
play
import
role
initi
develop
chronic
inflamm
transcript
induc
oxpapc
last
least
h
peak
mrna
express
approxim
h
follow
oxpapc
treatment
contrast
tnfainduc
transcript
reach
peak
h
remain
increas
h
follow
treatment
unlik
classic
inflammatori
mediat
lp
tnfa
induct
inflammatori
mediat
gene
oxpl
achiev
differ
transcript
mechan
transcript
induc
tnfa
mainli
nuclear
factor
kb
nfkb
pathway
activ
transcript
oxpl
howev
independ
nfkb
pathway
may
mediat
variou
pathway
includ
pathway
pparg
pathway
enossrebp
upr
src
kinas
particip
growth
factorcytokin
signal
transduct
pathway
mediat
prolifer
surviv
differenti
apoptosi
oxpapc
activ
src
kinas
downstream
effector
regul
transcript
bind
gammainterferon
activ
sequenc
element
promot
moreov
activ
src
kinas
oxpapc
independ
campprotein
kinas
pka
pathway
use
oxpapc
activ
integrin
monocyt
bind
mention
evid
indic
oxpapc
activ
srebp
human
artifici
episom
chromosom
h
treatment
activ
persist
h
investig
provid
evid
role
endotheli
nitric
oxid
synthas
eno
activ
srebp
oxpapc
oxpapc
treatment
ec
induc
doseand
timedepend
activ
eno
no
inhibitor
nnitrolargininemethyl
ester
significantli
inhibit
srebp
activ
synthesi
oxpapc
recent
find
shown
role
upr
signal
cascad
oxpapcinduc
induct
inflammatori
cytokin
immunohistochem
analysi
human
atherosclerot
lesion
indic
activ
upr
area
contain
oxpl
small
interf
rna
sirna
mediat
knockdown
branch
upr
downregul
basal
oxpapcstimul
express
cxc
motif
ligand
human
arteri
ec
inhibit
upr
pharmacolog
inhibitor
knockdown
cochaperon
decreas
vegf
mrna
induct
oxpl
express
level
vegf
oxpltreat
cell
strongli
correl
induct
target
gene
chromatin
immunoprecipit
assay
demonstr
oxpl
stimul
bind
regulatori
site
vegf
gene
enhanc
thrombogenesi
tissu
factor
tf
cellsurfac
receptor
factor
viia
play
import
role
thrombu
format
tf
express
subendotheli
cell
normal
expos
circul
blood
ec
express
tf
expos
inflammatori
molecul
oxpapc
induc
phosphoryl
extracellular
signal
express
earli
growth
respons
signal
requir
enhanc
tf
express
studi
bochkov
et
al
show
oxpapc
induc
express
tf
ec
methyl
ethyl
ketonespecif
inhibitor
suppress
activ
well
tf
increas
indic
protein
kinas
c
pkc
pathway
pathway
contribut
tf
induct
oxpapc
addit
oxpapcinduc
increas
cytosol
ca
activ
calcineurin
led
nuclear
transloc
dna
bind
nuclear
factor
activ
cell
thu
thrombogen
switch
induc
oxpapc
endothelium
promot
gener
procoagul
state
characterist
atherosclerosi
inflamm
increas
oxid
stress
excess
gener
ro
contribut
lung
inflamm
injuri
sever
observ
suggest
oxpl
may
induc
gener
excess
ro
ec
shortchain
polar
lipid
deriv
caus
glutathion
deplet
ec
oxpapcinduc
nicotinamid
adenin
dinucleotid
phosphat
oxidas
activ
appar
sourc
increas
superoxid
product
lead
glutathion
deplet
pathway
use
oxpapc
gener
ro
includ
uncoupl
eno
increas
mitochondri
metabol
parallel
increas
oxid
stress
oxpapc
may
induc
transcript
antioxid
enzym
okl
newli
recogn
antioxid
gene
induc
superoxid
product
respons
oxpapc
stimul
okl
express
oxpapc
mediat
transcript
factor
nuclear
factor
factor
antiinflammatori
effect
oxpl
oxpl
also
exhibit
antiinflammatori
protect
effect
context
sepsi
acut
injuri
antiinflammatori
effect
oxpl
includ
inhibit
steril
acut
lung
injuri
ali
induc
viral
bacteri
deriv
inflammatori
mediat
inhibit
asept
ali
induc
injuri
mechan
ventil
therefor
use
peipc
pecpclik
stabil
compound
may
show
benefici
effect
asept
lung
injuri
model
ischemiareperfus
inhibit
lung
vascular
leak
inflamm
secondari
ali
induc
acut
necrot
pancreat
inhibit
dendrit
cell
matur
antiinflammatori
effect
mediat
enhanc
endotheli
barrier
function
induct
signal
pathway
lead
upregul
antiinflammatori
gene
inhibit
proinflammatori
gene
express
prevent
interact
proinflammatori
bacteri
product
host
cell
signal
pathway
mediat
antiinflammatori
effect
oxpl
may
overlap
signal
pathway
mediat
proinflammatori
effect
follow
section
discuss
oxpl
function
detail
role
oxpl
endotheli
barrier
function
vascular
endotheli
barrier
circul
blood
interstiti
fluid
dynam
regul
counterbal
barrierprotect
barrierdisrupt
bioactiv
molecul
present
circul
maintain
balanc
critic
prevent
transmigr
inflammatori
cell
blood
vessel
interstiti
tissu
previou
studi
shown
treatment
pulmonari
ec
oxpapc
mg
ml
enhanc
basal
ec
monolay
barrier
properti
dosedepend
manner
last
h
oxpapc
pretreat
attenu
ec
permeabl
induc
thrombin
lp
highmagnitud
cyclic
stretch
acceler
recoveri
compromis
ec
barrier
function
analysi
structurefunct
relationship
show
oxid
product
arachidon
acid
linol
acidcontain
phospholipid
well
phospholipid
exhibit
barrierprotect
properti
pulmonari
ec
note
nonoxid
phospholipid
affect
basal
agonistinduc
permeabl
ec
oxpapc
protect
effect
verifi
rodent
model
lpsinduc
lung
injuri
vili
model
pulmonari
ec
expos
highmagnitud
cyclic
stretch
thrombin
stimul
signal
mechan
underli
ec
barrierprotect
effect
oxpapc
involv
small
gtpase
rho
rac
play
pivot
role
regul
cytoskelet
focal
adhes
adhes
junction
rac
signal
promot
ec
barrierprotect
function
oxpapcinduc
activ
rac
pulmonari
ec
lead
enhanc
peripher
actin
cytoskeleton
format
microspikelik
actin
structur
cellcel
interfac
coexpress
constitut
activ
rac
reproduc
uniqu
actin
rearrang
observ
oxpapcstimul
ec
monolay
analysi
upstream
mechan
show
involv
pka
src
pkc
activ
oxpapcinduc
activ
molecular
mechan
barrierprotect
effect
pka
may
caus
abil
attenu
endotheli
myosin
light
chain
mlc
kinas
activ
lead
decreas
basal
level
mlc
phosphoryl
pakmedi
inhibit
rho
activ
phosphoryl
actinbind
protein
filamin
adductin
dematin
well
focal
adhes
protein
paxillin
focal
adhes
kinas
fak
protein
lead
disappear
stress
fiber
factin
membran
ruffl
studi
also
indic
oxpapc
induc
phosphoryl
cofillin
promot
peripher
actin
polymer
addit
oxpapc
induc
phosphoryl
membran
transloc
focal
adhes
protein
paxillin
fak
recent
studi
demonstr
potenti
role
paxillin
feedback
mechan
rac
regul
focal
adhes
oxpapcstimul
ec
express
paxillin
mutat
attenu
oxpapcinduc
activ
ec
barrierprotect
respons
use
sirna
approach
provid
evid
rac
guanin
nucleotid
exchang
factor
bpix
involv
oxpapcinduc
rac
activ
ec
barrier
protect
respons
oxpapc
treatment
protect
effect
oxpl
lpsinduc
inflamm
lp
outer
membran
compon
gramneg
bacteria
known
endotoxin
induc
varieti
proinflammatori
gene
lead
septic
shock
death
sever
studi
perform
elucid
molecular
mechan
underli
lpsinduc
inflamm
lp
bind
serumbind
protein
call
lp
bind
protein
deliv
phosphatidylinositol
glycanlink
cell
surfac
protein
complex
interact
accessori
protein
recruit
adaptor
protein
mal
cytoplasm
domain
downstream
signal
pathway
includ
nfkb
transcript
factor
inflammatori
insult
cell
produc
plethora
ro
modifi
phospholipid
peroxid
lead
gener
oxpl
thu
oxpl
may
repres
neg
feedback
mechan
induc
excess
inflamm
oxldl
oxpl
inhibit
activ
nfkb
induc
lp
cpg
dna
oxldl
inhibit
lpsinduc
protein
express
express
activ
macrophag
well
induct
eselectin
protein
express
ec
induc
lp
lysophosphatidylcholin
inhibit
lp
induct
tf
monocyt
bochkov
et
al
reveal
mechan
oxpapc
inhibitori
effect
lpsinduc
inflamm
use
vitro
vivo
model
inhibitori
effect
oxpapc
specif
lp
inflammatori
agonist
tnfa
oxpapc
inhibit
lp
signal
block
bind
lp
lbp
later
studi
walton
et
al
propos
altern
mechan
via
oxpapcinduc
disrupt
caveola
inhibit
assembl
lp
signal
complex
ec
addit
block
inflammatori
signal
cascad
studi
suggest
independ
inhibitori
mechan
mention
oxpapc
may
also
attenu
lpsinduc
vili
via
direct
enhanc
vascular
endotheli
barrier
function
antiinflammatori
mechan
activ
oxpl
antiinflammatori
effect
increas
camp
intracellular
concentr
previous
describ
increas
camp
level
inhibit
eselectin
express
ec
inhibit
oxid
burst
neutrophil
suppress
map
kinas
upregul
suppressor
cytokin
signal
heme
enzym
mediat
catabol
heme
carbon
monoxid
human
endotheli
smooth
muscl
cell
antiinflammatori
effect
mediat
gener
carbon
monoxid
inhibit
express
tnfa
macrophag
inflammatori
protein
moreov
induc
express
antiinflammatori
turn
upregul
express
anoth
enzym
involv
oxplmedi
antiinflammatori
signal
resolut
inflamm
express
induc
oxpl
campresponseelementbindingproteindepend
ppargdepend
manner
oxpl
may
also
activ
eno
increas
product
associ
mani
antiinflammatori
activ
includ
downregul
adhes
molecul
suppress
chemokin
product
inhibit
leukocyt
extravas
summari
find
indic
oxpl
induc
sever
antiinflammatori
signal
molecul
transcript
factor
decreas
express
inflammatori
cytokin
patholog
condit
associ
acut
injuri
local
inflamm
gener
oxpl
gener
featur
lung
injuri
accompani
activ
ro
product
induc
differ
pathogen
infect
studi
imai
et
al
show
accumul
oxid
phosphorylcholin
product
human
anim
lung
infect
sever
acut
respiratori
syndrom
viru
avian
influenza
viru
anthrax
well
mous
model
acidinduc
lung
injuri
studi
also
suggest
involv
oxpl
develop
ali
oxpl
increas
studi
monitor
tissu
stain
monoclon
antibodi
potent
antigen
antibodi
product
aldol
condens
fragment
product
papc
oxid
p
povpc
vpc
diovpc
well
schiff
base
form
coval
bond
protein
lysin
residu
aldehyd
group
fragment
oxid
phospholipid
povpcbovin
serum
albumin
discuss
fragment
pl
oxid
product
induc
endotheli
barrier
disrupt
see
tabl
thu
antibodi
discrimin
barrierprotect
barrierdisrupt
oxpl
gener
oxpl
bronchioalveolar
lavag
alveolar
macrophag
may
repres
accumul
fragment
papc
oxid
product
aldol
condens
schiff
base
rather
increas
level
peipc
pecpc
oxpapc
dose
use
intratrach
instil
mgg
bodi
weight
affect
lung
elast
paramet
time
higher
compar
dose
use
studi
show
protect
effect
model
lpsinduc
cpg
dnainduc
ali
also
seem
anim
model
lpsinduc
lung
injuri
vili
well
lung
dysfunct
associ
acut
necrot
pancreat
higher
oxpapc
dose
mgkg
may
well
toler
administ
intraven
dose
promot
vascular
endotheli
barrier
function
turn
patholog
effect
high
dose
intratrach
oxpapc
may
caus
direct
effect
oxpapc
alveolar
epitheli
cell
precis
effect
oxpapc
alveolar
epitheli
permeabl
physiolog
respons
yet
test
possibl
oxpapc
report
dose
may
caus
barrierdisrupt
effect
epitheli
cell
possibl
need
test
consist
notion
deleteri
effect
high
local
oxpapc
dose
lung
elast
vivo
high
oxpapc
concentr
also
caus
endotheli
barrier
dysfunct
vitro
quantit
qualit
analysi
oxpl
gener
ali
tissu
sampl
use
mass
spectrometri
approach
still
remain
perform
import
studi
improv
character
composit
endogen
oxpl
gener
injur
lung
well
understand
role
pathogenesi
ali
mani
publish
studi
support
notion
cellular
respons
oxpl
critic
depend
local
oxpl
concentr
thu
oxpl
may
play
dual
role
progress
ali
acut
phase
high
concentr
oxpl
may
exert
barrier
dysfunct
effect
wherea
decreas
oxpl
concentr
later
phase
injuri
restor
vascular
barrier
contribut
resolut
lung
inflamm
injuri
addit
studi
requir
test
hypothesi
oxpl
gener
variou
patholog
condit
exhibit
broad
rang
biolog
activ
includ
proinflammatori
antiinflammatori
effect
well
regul
lung
permeabl
unlik
classic
inflammatori
factor
oxpl
trigger
uniqu
mechan
lead
activ
inflammatori
signal
pathway
stimul
inflammatori
transcript
factor
express
inflammatori
cytokin
gener
excess
ro
howev
oxpl
potent
inhibitor
acut
inflamm
mediat
tlr
famili
specif
group
cyclopenthenonecontain
oxpl
includ
peipc
pecpc
induc
potent
barrierprotect
respons
vascular
ec
inhibit
hyperperm
induc
edemagen
agonist
mediat
inflamm
patholog
mechan
strain
thu
increas
oxpl
level
observ
cours
acut
inflamm
bacteri
infect
acut
tissu
injuri
may
repres
neg
feedback
mechan
lead
downregul
cellular
inflammatori
cascad
addit
screen
character
oxpl
compound
barrierprotect
antiinflammatori
properti
synthesi
bioactiv
oxpl
deriv
stabil
structur
may
excit
area
research
could
potenti
lead
new
group
pharmacolog
molecul
benefici
treatment
vili
acut
respiratori
distress
syndrom
lung
inflamm
diseas
associ
increas
vascular
leakag
